Article Archive

In the high-stakes world of drug development, bringing a new drug to market represents the culmination of years—often decades—of scientific innovation, clinical research, and regulatory strategy. At the center of this journey stands the U.S. Food and Drug Administration (FDA),…

For biopharmaceutical companies, successfully completing Phase 3 clinical trials represents a pivotal milestone in drug development. However, this achievement marks not the end but rather the beginning of the final and often most scrutinized stage of the regulatory approval process.…

Late-stage pharmaceutical development represents a critical juncture where years of research and substantial investment converge toward market approval. At this phase, unexpected obstacles can trigger cascading delays with significant financial implications for promising compounds. This article examines common pitfalls that…

The journey of a pharmaceutical compound from laboratory conception to market availability is a multifaceted process fraught with challenges. The answer to what are the 4 stages of drug development provides a useful framework. Among the four stages of drug…

Navigating the FDA regulatory action process presents unique challenges, and unexpected setbacks can stall even the most promising development programs. FDA Type A Meetings provide sponsors with an opportunity to obtain regulatory advice and timely feedback on critical issues affecting…

Bringing a new drug to market is a long and highly regulated process designed to ensure safety, efficacy, and quality. The pharmaceutical drug development process moves through multiple stages—beginning with drug discovery, advancing through preclinical and clinical research, and ultimately…